688358 祥生医疗
午间休市 01-12 11:29:50
资讯
新帖
简况
祥生医疗业绩承压仍高比例分红，募投项目延期引担忧
新浪证券 · 01-09 17:38
祥生医疗业绩承压仍高比例分红，募投项目延期引担忧
祥生医疗的经营焦虑：业绩连降、应收账激增、募投延期
市场资讯 · 01-04
祥生医疗的经营焦虑：业绩连降、应收账激增、募投延期
每周股票复盘：祥生医疗（688358）2025年前三季度利润分配方案获高票通过
证券之星 · 01-02
每周股票复盘：祥生医疗（688358）2025年前三季度利润分配方案获高票通过
祥生医疗（688358）披露2025年前三季度利润分配方案，12月31日股价上涨0.27%
证券之星 · 2025-12-31
祥生医疗（688358）披露2025年前三季度利润分配方案，12月31日股价上涨0.27%
每周股票复盘：祥生医疗（688358）拟每10股派3元现金红利
证券之星 · 2025-12-28
每周股票复盘：祥生医疗（688358）拟每10股派3元现金红利
祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果公告，12月25日股价上涨1.2%
证券之星 · 2025-12-25
祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果公告，12月25日股价上涨1.2%
祥生医疗：变更公司注册资本、修订《公司章程》并办理工商变更登记
证券日报网 · 2025-12-14
祥生医疗：变更公司注册资本、修订《公司章程》并办理工商变更登记
祥生医疗拟将两项募投项目延期
北京商报 · 2025-12-14
祥生医疗拟将两项募投项目延期
祥生医疗前三季度利润分配方案：拟每10股派3元
证券之星 · 2025-12-14
祥生医疗前三季度利润分配方案：拟每10股派3元
祥生医疗（688358）披露2025年限制性股票激励计划股份授予进展，11月28日股价上涨0.96%
证券之星 · 2025-11-28
祥生医疗（688358）披露2025年限制性股票激励计划股份授予进展，11月28日股价上涨0.96%
祥生医疗（688358）披露股东提前终止减持计划暨减持股份结果公告，11月25日股价上涨2.12%
证券之星 · 2025-11-25
祥生医疗（688358）披露股东提前终止减持计划暨减持股份结果公告，11月25日股价上涨2.12%
每周股票复盘：祥生医疗（688358）Q3净利增41.95%
证券之星 · 2025-11-09
每周股票复盘：祥生医疗（688358）Q3净利增41.95%
祥生医疗（688358）披露持股5%以上股东权益变动触及1%刻度的提示性公告，11月07日股价下跌0.6%
证券之星 · 2025-11-07
祥生医疗（688358）披露持股5%以上股东权益变动触及1%刻度的提示性公告，11月07日股价下跌0.6%
11月6日祥生医疗现2131.64万元大宗交易
证券之星 · 2025-11-06
11月6日祥生医疗现2131.64万元大宗交易
【机构调研记录】恒生前海基金调研祥生医疗、汉钟精机
证券之星 · 2025-11-04
【机构调研记录】恒生前海基金调研祥生医疗、汉钟精机
祥生医疗：10月20日召开业绩说明会，包括知名机构易鑫安资管，高毅资产的多家机构参与
证券之星 · 2025-11-03
祥生医疗：10月20日召开业绩说明会，包括知名机构易鑫安资管，高毅资产的多家机构参与
11月3日祥生医疗现3笔大宗交易 机构净买入502.45万元
证券之星 · 2025-11-03
11月3日祥生医疗现3笔大宗交易 机构净买入502.45万元
每周股票复盘：祥生医疗（688358）Q3净利增41.95%
证券之星 · 2025-10-26
每周股票复盘：祥生医疗（688358）Q3净利增41.95%
祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件，10月24日股价上涨4.75%
证券之星 · 2025-10-24
祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件，10月24日股价上涨4.75%
祥生医疗涨6.62%，太平洋一个月前给出“买入”评级
证券之星 · 2025-10-21
祥生医疗涨6.62%，太平洋一个月前给出“买入”评级
加载更多
公司概况
公司名称：
无锡祥生医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-12-03
主营业务：
无锡祥生医疗科技股份有限公司的主营业务是超声医学影像设备的研发、制造和销售。公司的主要产品是超声医学影像设备。公司入选2024年度国家专精特新“小巨人”企业。
发行价格：
50.53
{"stockData":{"symbol":"688358","market":"SH","secType":"STK","nameCN":"祥生医疗","latestPrice":37.63,"timestamp":1768188590000,"preClose":35.45,"halted":0,"volume":4506034,"delay":0,"changeRate":0.0615,"floatShares":112000000,"shares":112000000,"eps":1.2131,"marketStatus":"午间休市","change":2.18,"latestTime":"01-12 11:29:50","open":35.78,"high":38.3,"low":35.78,"amount":167000000,"amplitude":0.0711,"askPrice":37.66,"askSize":2,"bidPrice":37.61,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.2131,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768194000000},"marketStatusCode":3,"adr":0,"adjPreClose":35.45,"symbolType":"stock_kcb","openAndCloseTimeList":[[1768181400000,1768188600000],[1768194000000,1768201200000]],"highLimit":39,"lowLimit":31.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112125613,"isCdr":false,"pbRate":2.84,"roa":"--","peRate":31.019702,"roe":"6.63%","epsLYR":1.26,"committee":0.217391,"marketValue":4219000000,"turnoverRate":0.0402,"status":0,"floatMarketCap":4214000000},"requestUrl":"/m/hq/s/688358","defaultTab":"news","newsList":[{"id":"2602290323","title":"祥生医疗业绩承压仍高比例分红，募投项目延期引担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2602290323","media":"新浪证券","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602290323?lang=zh_cn&edition=full","pubTime":"2026-01-09 17:38","pubTimestamp":1767951480,"startTime":"0","endTime":"0","summary":"在营收与净利润连续两年下滑的背景下，祥生医疗2025年前三季度业绩仍未见起色。不过，公司近期仍决定实施现金分红，分红金额占前三季度归母净利润的35.73%，这一举措被市场解读为意在稳定投资者信心。 然而，伴随应收账款规模较上年末大幅增长22%，公司资金回笼压力持续上升，加之两项核心募投项目双双延期至2026年底，祥生医疗在股东回报、现金流管理与长期战略投入之间的平衡正面临严峻考验。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-01-09/doc-inhftcfr0482838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2600304430","title":"祥生医疗的经营焦虑：业绩连降、应收账激增、募投延期","url":"https://stock-news.laohu8.com/highlight/detail?id=2600304430","media":"市场资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600304430?lang=zh_cn&edition=full","pubTime":"2026-01-04 16:21","pubTimestamp":1767514860,"startTime":"0","endTime":"0","summary":" 在延续2024年营收、净利润双降的背景下，祥生医疗今年前三季度业绩继续承压。然而，伴随应收账款规模较上年末增长22%，资金回笼压力持续加大，市场对其现金流健康状况的关注也随之升温。 证券之星注意到，祥生医疗两项关键募投项目——“研发创新及营销运营基地建设”与“创新与发展储备资金”已双双延期至2026年底。如何平衡股东回报、资金安全与战略投入，是祥生医疗面临的核心课题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2026-01-04/doc-inhfctqq7450646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2600039533","title":"每周股票复盘：祥生医疗（688358）2025年前三季度利润分配方案获高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2600039533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600039533?lang=zh_cn&edition=full","pubTime":"2026-01-02 03:56","pubTimestamp":1767297361,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，祥生医疗报收于30.1元，较上周的30.55元下跌1.47%。本周，祥生医疗12月22日盘中最高价报31.29元。本周关注点公司公告汇总：祥生医疗2025年第三次临时股东会审议通过前三季度利润分配方案，获99.9987%股东同意。公司公告汇总：中小投资者对利润分配方案的支持率达99.9903%，显示高度认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200001141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2595077890","title":"祥生医疗（688358）披露2025年前三季度利润分配方案，12月31日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595077890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595077890?lang=zh_cn&edition=full","pubTime":"2025-12-31 18:02","pubTimestamp":1767175363,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，祥生医疗报收于30.1元，较前一交易日上涨0.27%，最新总市值为33.75亿元。该股当日开盘30.0元，最高30.25元，最低29.74元，成交额达1692.73万元，换手率为0.5%。公司近日发布公告称，无锡祥生医疗科技股份有限公司于2025年12月30日召开2025年第三次临时股东会，审议通过《关于2025年前三季度利润分配方案的议案》。议案获普通股股东99.9987%同意通过，中小投资者同意比例为99.9903%。上海市通力律师事务所见证并出具法律意见书，认为本次会议合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100033397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2594820247","title":"每周股票复盘：祥生医疗（688358）拟每10股派3元现金红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2594820247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594820247?lang=zh_cn&edition=full","pubTime":"2025-12-28 04:44","pubTimestamp":1766868250,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，祥生医疗报收于30.1元，较上周的30.55元下跌1.47%。本周，祥生医疗12月22日盘中最高价报31.29元。本周关注点公司公告汇总：祥生医疗拟以2025年前三季度净利润为基础，向全体股东每10股派发现金红利3元（含税）。公司公告汇总：祥生医疗完成2024年限制性股票激励计划首次授予部分第一个归属期股份登记，归属数量为100,860股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800001226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2594323704","title":"祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期归属结果公告，12月25日股价上涨1.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594323704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594323704?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:50","pubTimestamp":1766674231,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，祥生医疗报收于30.37元，较前一交易日上涨1.2%，最新总市值为34.05亿元。近日，祥生医疗发布《2024年限制性股票激励计划首次授予部分第一个归属期归属结果公告》。公告显示，公司已完成2024年限制性股票激励计划首次授予部分第一个归属期的股份登记，本次归属数量为100,860股，来源于公司回购的A股普通股股票，归属对象为26名中层管理人员、技术骨干及业务骨干，占已获授予权益总额的26.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2591253666","title":"祥生医疗：变更公司注册资本、修订《公司章程》并办理工商变更登记","url":"https://stock-news.laohu8.com/highlight/detail?id=2591253666","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591253666?lang=zh_cn&edition=full","pubTime":"2025-12-14 22:09","pubTimestamp":1765721340,"startTime":"0","endTime":"0","summary":"证券日报网讯12月14日晚间，祥生医疗发布公告称，公司已于2025年12月10日在中国证券登记结算有限公司上海分公司办理完成2025年限制性股票激励计划的股票授予登记工作，股本总数由112124537股增至112125613股，注册资本相应由112124537.00元增至112125613.00元，并据此修订《公司章程》注册资本及股份总数条款，办理工商变更登记。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-14/doc-inhauuyz4808107.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-14/doc-inhauuyz4808107.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2591666569","title":"祥生医疗拟将两项募投项目延期","url":"https://stock-news.laohu8.com/highlight/detail?id=2591666569","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591666569?lang=zh_cn&edition=full","pubTime":"2025-12-14 18:52","pubTimestamp":1765709520,"startTime":"0","endTime":"0","summary":"祥生医疗表示，结合目前公司募集资金投资项目的实际建设情况和投资进度，在募集资金投资用途及投资规模不发生变更的情况下，对研发创新及营销运营基地建设项目、创新与发展储备资金两个项目达到预定可使用状态日期进行调整，原计划项目达到预定可使用状态日期为2025年12月31日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-14/doc-inhaukmf5030473.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-14/doc-inhaukmf5030473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2591865709","title":"祥生医疗前三季度利润分配方案：拟每10股派3元","url":"https://stock-news.laohu8.com/highlight/detail?id=2591865709","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591865709?lang=zh_cn&edition=full","pubTime":"2025-12-14 16:00","pubTimestamp":1765699208,"startTime":"0","endTime":"0","summary":"祥生医疗(688358.SH)公告称，经公司第三届董事会第十七次会议审议通过，公司拟以实施权益分派股权登记日登记的总股本扣减公司回购专用证券账户中的股份为基数分配利润。本次利润分配方案如下：公司拟向全体股东每10股派发现金红利3元（含税）。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121400002031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2586733713","title":"祥生医疗（688358）披露2025年限制性股票激励计划股份授予进展，11月28日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586733713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586733713?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:36","pubTimestamp":1764340608,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘，祥生医疗报收于31.61元，较前一交易日上涨0.96%，最新总市值为35.44亿元。该股当日开盘31.46元，最高31.7元，最低31.05元，成交额达1905.5万元，换手率为0.54%。近日，祥生医疗发布关于股份性质变更暨2025年限制性股票激励计划股份授予的进展公告。公告显示，公司于2025年10月23日确定向17名激励对象授予160,000股限制性股票，授予价格为16.50元/股。因1名激励对象放弃认购，最终16名激励对象实际认购150,000股，缴款总额为2,475,000.00元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800040842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2586222426","title":"祥生医疗（688358）披露股东提前终止减持计划暨减持股份结果公告，11月25日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586222426","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586222426?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:53","pubTimestamp":1764064388,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，本次减持计划实施前，莫若理女士及其一致行动人合计持有公司股份80,723,956股，占公司总股本的71.99%。莫若理女士拟减持不超过3,363,735股，计划期间为2025年9月5日至12月4日。截至2025年11月21日，莫若理女士通过集中竞价和大宗交易方式合计减持1,815,994股，占公司总股本的1.62%，减持完成后持股比例降至21.98%。基于对公司持续稳定发展的信心，莫若理女士决定提前终止减持计划。本次权益变动后，莫若理及其一致行动人持股比例由71.99%降至70.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500027323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2582106861","title":"每周股票复盘：祥生医疗（688358）Q3净利增41.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582106861","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582106861?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:07","pubTimestamp":1762632431,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，祥生医疗报收于34.92元，较上周的34.94元下跌0.06%。本周，祥生医疗11月3日盘中最高价报37.07元。11月3日祥生医疗发生3笔大宗交易，机构净买入502.45万元。机构调研要点2025年第三季度，公司实现营业收入1.07亿元，同比下降6.68%；归母净利润2422.41万元，同比增长41.95%；扣非净利润2314.06万元，同比增长53.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2581288927","title":"祥生医疗（688358）披露持股5%以上股东权益变动触及1%刻度的提示性公告，11月07日股价下跌0.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581288927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581288927?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:33","pubTimestamp":1762526008,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，祥生医疗报收于34.92元，较前一交易日下跌0.6%，最新总市值为39.15亿元。公司近日发布公告称，无锡祥生医疗科技股份有限公司于2025年9月5日至11月6日期间，股东莫若理通过集中竞价及大宗交易方式累计减持公司股份1,783,139股，占公司总股本的1.59%。本次权益变动后，莫若理及其一致行动人合计持股比例由71.99%减少至70.40%，触及1%整数倍。本次变动未导致公司控股股东及实际控制人变化，不触及要约收购，亦未违反此前承诺。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700039354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2581050369","title":"11月6日祥生医疗现2131.64万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2581050369","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581050369?lang=zh_cn&edition=full","pubTime":"2025-11-06 17:29","pubTimestamp":1762421385,"startTime":"0","endTime":"0","summary":"证券之星消息，11月6日祥生医疗发生大宗交易，交易数据如下：近三个月该股共发生8笔大宗交易，合计成交1.16万手，折价成交8笔。该股近期无解禁股上市。截至2025年11月6日收盘，祥生医疗(688358)报收于35.13元，上涨0.09%，换手率1.65%，成交量1.85万手，成交额6520.13万元。该股最近90天内共有4家机构给出评级，买入评级4家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600027311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2580227050","title":"【机构调研记录】恒生前海基金调研祥生医疗、汉钟精机","url":"https://stock-news.laohu8.com/highlight/detail?id=2580227050","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580227050?lang=zh_cn&edition=full","pubTime":"2025-11-04 08:06","pubTimestamp":1762214784,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月3日披露的机构调研信息，恒生前海基金近期对2家上市公司进行了调研，相关名单如下：1）祥生医疗 调研纪要：2025年第三季度营收1.07亿元，同比下降6.68%，归母净利润2422.41万元，同比增长41.95%。2）汉钟精机 调研纪要：2025年前三季度营业收入22.65亿元，同比下降20.70%，净利润3.92亿元，同比下降45.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400005756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0172","688358","002158","BK0251","BK0151","BK0188","BK0117","BK0259"],"gpt_icon":0},{"id":"2580329595","title":"祥生医疗：10月20日召开业绩说明会，包括知名机构易鑫安资管，高毅资产的多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2580329595","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580329595?lang=zh_cn&edition=full","pubTime":"2025-11-03 18:02","pubTimestamp":1762164165,"startTime":"0","endTime":"0","summary":"祥生医疗主营业务：超声医学影像设备的研发、制造和销售,为国内外医疗机构、科研机构、战略合作伙伴等提供各类超声医学影像设备和专业的技术开发服务。该股最近90天内共有4家机构给出评级，买入评级4家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300025387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2580379293","title":"11月3日祥生医疗现3笔大宗交易 机构净买入502.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580379293","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580379293?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:33","pubTimestamp":1762162386,"startTime":"0","endTime":"0","summary":"证券之星消息，11月3日祥生医疗发生大宗交易，交易数据如下：近三个月该股共发生3笔大宗交易，合计成交4944.0手，折价成交3笔。该股近期无解禁股上市。截至2025年11月3日收盘，祥生医疗(688358)报收于35.81元，上涨2.49%，换手率2.84%，成交量3.18万手，成交额1.15亿元。该股最近90天内共有4家机构给出评级，买入评级4家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300024238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2578450709","title":"每周股票复盘：祥生医疗（688358）Q3净利增41.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578450709","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578450709?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:19","pubTimestamp":1761423547,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，祥生医疗报收于35.27元，较上周的32.62元上涨8.12%。本周，祥生医疗10月24日盘中最高价报36.26元。股本股东变化截至2025年9月30日，祥生医疗股东户数为6,167户，较6月30日减少464户，减幅7.0%。业绩披露要点2025年第三季度，祥生医疗营业收入为1.07亿元，同比下降6.68%；归属于上市公司股东的净利润为2,422.41万元，同比增长41.95%；扣除非经常性损益后的净利润为2,314.06万元，同比增长53.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688358","BK0251"],"gpt_icon":0},{"id":"2577592385","title":"祥生医疗（688358）披露2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件，10月24日股价上涨4.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577592385","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577592385?lang=zh_cn&edition=full","pubTime":"2025-10-24 18:08","pubTimestamp":1761300529,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，祥生医疗报收于35.27元，较前一交易日上涨4.75%，最新总市值为39.55亿元。同日，祥生医疗发布《关于2024年限制性股票激励计划首次授予部分第一个归属期符合归属条件的公告》。首次授予日为2024年10月22日，归属时间为2025年10月23日至2026年10月22日。首次授予激励对象30人，其中26人符合归属条件，3人因离职、1人因考核不合格导致其权益作废。董事会薪酬与考核委员会及律师事务所均认为本次归属符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400032284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688358"],"gpt_icon":0},{"id":"2577842524","title":"祥生医疗涨6.62%，太平洋一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2577842524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577842524?lang=zh_cn&edition=full","pubTime":"2025-10-21 16:10","pubTimestamp":1761034248,"startTime":"0","endTime":"0","summary":"今日祥生医疗（688358）涨6.62%，收盘报34.93元。2025年9月14日，太平洋研究员谭紫媚,李啸岩发布了对祥生医疗的研报《祥生医疗：业绩符合预期，创新管线稳步推进》，该研报对祥生医疗给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为78.58%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为太平洋的李啸岩。祥生医疗（688358）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100023428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","688358"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768192871272,"stockEarnings":[{"period":"1week","weight":0.1777},{"period":"1month","weight":0.175},{"period":"3month","weight":0.0476},{"period":"6month","weight":0.2117},{"period":"1year","weight":0.548},{"period":"ytd","weight":0.1777}],"compareEarnings":[{"period":"1week","weight":0.0382},{"period":"1month","weight":0.0564},{"period":"3month","weight":0.0573},{"period":"6month","weight":0.1739},{"period":"1year","weight":0.2831},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"无锡祥生医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6167人(较上一季度减少7.00%)","perCapita":"18157股","listingDate":"2019-12-03","address":"江苏省无锡市新吴区长江南路3号","registeredCapital":"11212万元","survey":" 无锡祥生医疗科技股份有限公司的主营业务是超声医学影像设备的研发、制造和销售。公司的主要产品是超声医学影像设备。公司入选2024年度国家专精特新“小巨人”企业。","listedPrice":50.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"祥生医疗(688358)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供祥生医疗(688358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"祥生医疗,688358,祥生医疗股票,祥生医疗股票老虎,祥生医疗股票老虎国际,祥生医疗行情,祥生医疗股票行情,祥生医疗股价,祥生医疗股市,祥生医疗股票价格,祥生医疗股票交易,祥生医疗股票购买,祥生医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"祥生医疗(688358)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供祥生医疗(688358)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}